BIOS Overview

  • Founded
  • 2015

Founded

  • Status
  • Private

  • Employees
  • 39

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $20M

  • Investors
  • 26

BIOS General Information

Description

Developer of prosthetic connectors designed to standardize the connection between bionic devices and neural and soft-tissue systems within the body. The company's connectors are implanted medical devices that can be inserted into the end of an amputated limb, and to precisely link nerve activity to specific conditions through the discovery of their neural biomarkers is a game changer for precision medicine, crossing through the skin barrier to provide a permanent attachment site for any prosthetic, enabling patients to have neural control and feedback from prosthetic connectors easily.

Contact Information

Website
www.bios.health
Formerly Known As
Cambridge Bio-Augmentation Systems, CBAS
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Primary Office
  • 8 Bateman News
  • Cambridge CB2 1NN
  • England, United Kingdom

BIOS Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BIOS Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Later Stage VC 22-Jun-2023 $20M 00.000 00000 Completed Generating Revenue
13. Grant 25-Jul-2022 00.000 00.000 Completed Generating Revenue
12. Grant 13-Jul-2022 00000 00.000 Completed Generating Revenue
11. Grant 15-Feb-2021 00.00 00.000 Completed Generating Revenue
10. Grant 01-Mar-2020 00.000 00.000 Completed Generating Revenue
9. Seed Round 04-Dec-2018 00.00 00.000 0000 Completed Generating Revenue
8. Accelerator/Incubator 07-Sep-2017 00000 Completed Generating Revenue
7. Accelerator/Incubator 20-Mar-2017 00000 00000 00.000 Completed Generating Revenue
6. Seed Round 01-Jan-2017 $127K Completed Generating Revenue
5. Accelerator/Incubator 01-Jul-2016 $127K Completed Generating Revenue
To view BIOS’s complete valuation and funding history, request access »

BIOS Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of prosthetic connectors designed to standardize the connection between bionic devices and neural and soft-tis
Surgical Devices
Cambridge, United Kingdom
39 As of 2023
00.000
0000 0000-00-00
0000000000 0 00.000

000000

dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut
00000000000 0000000
Fremont, CA
000 As of 0000
00000
0.000 0000-00-00
00000000000 00000

000000

odo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse ci
0000000000 000000000
Los Angeles, CA
00 As of 0000
000.00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BIOS Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Neuralink Venture Capital-Backed Fremont, CA 000 00000 00000000000 00000
000000 Venture Capital-Backed Los Angeles, CA 00 000.00 0000000000 0 000.00
0000 0000 Venture Capital-Backed San Francisco, CA 00 000.00 000000 - 000 000.00
You’re viewing 3 of 3 competitors. Get the full list »

BIOS Patents

  • 52

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 6

    Granted

  • 5

    Pending

  • 000

    Expiring in next 12 mo

BIOS Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202214547-D0 Biomarker identification and treatment recommendation Pending 03-Oct-2022
AU-2020301632-A1 System and method for automated detection of clinical outcome measures Pending 26-Jun-2019 000000000
CA-3144315-A1 System and method for automated detection of clinical outcome measures Pending 26-Jun-2019 000000000
EP-3991181-A1 System and method for automated detection of clinical outcome measures Pending 26-Jun-2019 000000000
GB-201909211-D0 System and method for automated detection of clinical outcome measures Inactive 26-Jun-2019 G16H50/20
To view BIOS’s complete patent history, request access »

BIOS Executive Team (4)

Name Title Board Seat Contact Info
Emil Hewage Ph.D Co-Founder, Chief Executive Officer & Board Member
Paul Hughes Chief Operating Officer
Oliver Armitage Ph.D Co-Founder, Chief Scientific Officer & Director
Patrick Porritt Chief Business Officer & Head of Corporate Finance
To view BIOS’s complete executive team members history, request access »

BIOS Board Members (3)

Name Representing Role Since
Emil Hewage Ph.D BIOS Co-Founder, Chief Executive Officer & Board Member 000 0000
Joanne Hackett Self Chairman 000 0000
Oliver Armitage Ph.D BIOS Co-Founder, Chief Scientific Officer & Director 000 0000
To view BIOS’s complete board members history, request access »

BIOS Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BIOS Investors (26)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Selvedge Venture Venture Capital Minority 000 0000 000000 0
XTX Ventures Corporate Venture Capital Minority 000 0000 000000 0
McGill University University Minority 000 0000 000000 0
MEDTEQ Invest Not-For-Profit Venture Capital Minority 000 0000 000000 0
Mitacs Accelerator/Incubator Minority 000 0000 000000 0
You’re viewing 5 of 26 investors. Get the full list »

Ready to get started?

Request a free trial